Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Giulia Bellicini

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
European Journal of Heart Failure|July 20, 2022
Value of the HFA-PEFF and H<sub>2</sub> FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosisDaniela Tomasoni, Alberto Aimo, Marco Merlo, et al.
European Journal of Heart Failure|March 15, 2023
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosisAlberto Aimo, Daniela Tomasoni, Aldostefano Porcari, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
European Journal of Heart Failure|July 20, 2022
Value of the HFA-PEFF and H<sub>2</sub> FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosisDaniela Tomasoni, Alberto Aimo, Marco Merlo, et al.
European Journal of Heart Failure|March 15, 2023
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosisAlberto Aimo, Daniela Tomasoni, Aldostefano Porcari, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
Pageof 4